[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356629-105":59,"doc-detail-356629-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mitophagy-in-bladder-cancer-a-double-edged-sword-in-tumor-progression-and-therapy","Mitophagy in bladder cancer - a double-edged sword in tumor progression and therapy","","Bladder cancer remains highly lethal due to late-stage diagnosis, postoperative recurrence, and emerging resistance to existing treatments. Mitophagy, a selective autophagy pathway that removes dysfunctional mitochondria, is central to cellular homeostasis, and its dysregulation contributes to cancer and other diseases. This review integrates current mechanistic evidence on how mitophagy influences bladder cancer initiation, progression, and therapeutic responses, highlighting its context-dependent dual role.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mitophagy-in-bladder-cancer-a-double-edged-sword-in-tumor-progression-and-therapy/356629/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mitophagy-in-bladder-cancer-a-double-edged-sword-in-tumor-progression-and-therapy/356629.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is bladder cancer prognosis still poor despite advances in therapy?","Question",{"text":112,"@type":113},"Poor outcomes are driven by late-stage diagnosis, postoperative recurrence, and the development of resistance to chemotherapy and immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is mitophagy and why is it relevant to cancer biology?",{"text":117,"@type":113},"Mitophagy selectively degrades dysfunctional mitochondria, maintaining cellular homeostasis; abnormal regulation can promote cancer-associated mitochondrial damage and disease pathogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"How should mitophagy be targeted for treatment given its dual role?",{"text":121,"@type":113},"Because mitophagy can act as either a tumor promoter or suppressor depending on context, therapeutic strategies should focus on precise, individualized modulation rather than simple inhibition or activation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356629,1790193324,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Chen et al. Journal of Translational Medicine (2026) 24:523  \n[https://doi.org/10.1186/s12967-026-08042-z](https://doi.org/10.1186/s12967-026-08042-z)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nMitophagy in bladder cancer: a double-edged sword in tumor progression and therapy  \nQi Chen1, Tao Chen2, Lifeng Gan3, Yiran Lu3 and Biao Qian4*  \nAbstract  \nBackground Bladder cancer (BC) is the second most prevalent malignancy of the urinary system, characterized by high recurrence rates and aggressive behavior. Although treatment modalities have advanced, patient prognosis remains poor, largely due to late-stage diagnosis, postoperative recurrence, and the development of therapy resistance. Mitophagy, a selective form of autophagy responsible for degrading dysfunctional mitochondria, is a critical mechanism for maintaining cellular homeostasis. Dysregulation of mitophagy leads to the accumulation of damaged mitochondria and is implicated in the pathogenesis of numerous diseases, including cancer.  \nMain body This review synthesizes current understanding of the molecular mechanisms by which mitophagy regulates the initiation and progression of BC. Concurrently, we critically evaluate its context-dependent functions in disease biology and therapeutic response. The role of mitophagy in BC is dual and highly context-dependent. It can function as either a tumor promoter or a tumor suppressor, with its net effect determined by multiple factors, including tumor stage, genetic background, tumor microenvironment composition, and the extent of autophagic activation. While targeting mitophagy represents a promising therapeutic strategy, its functional duality necessitates approaches that extend beyond simple inhibition or activation. Future therapeutic development must therefore focus on precise, individualized modulation tailored to specific tumor contexts.  \nConclusion Mitophagy plays a multidimensional and pivotal role in BC pathogenesis and treatment response. A deeper understanding of its nuanced mechanisms not only advances the fundamental knowledge of BC pathology but also unveils innovative avenues for diagnosis and targeted therapy, offering a promising strategy to overcome current clinical challenges.  \nKeywords Mitophagy, Bladder cancer, Duality, Targeted therapy, Tumor microenvironment  \n*Correspondence:  \nBiao Qian  \n[qianbiao@gmu.edu.cn](qianbiao@gmu.edu.cn)  \n1Department of Urology, The Second Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi, China  \n2Xiangya Hospital, Central South University, Changsha, Hunan, China 3The First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China  \n4Department of Urology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nChen et al. Journal of Translational Medicine (2026) 24:523  \nIntroductio","cbCaijPL9r4hcsVy","https://ap.wps.com/l/cbCaijPL9r4hcsVy","pdf",1501160,15,"English","# Abstract\n# Introduction\n# Main body\n## Mitophagy as a dual regulator in bladder cancer\n## Implications for therapy and future directions\n# Conclusion","[{\"question\":\"Why is bladder cancer prognosis still poor despite advances in therapy?\",\"answer\":\"Poor outcomes are driven by late-stage diagnosis, postoperative recurrence, and the development of resistance to chemotherapy and immunotherapy.\"},{\"question\":\"What is mitophagy and why is it relevant to cancer biology?\",\"answer\":\"Mitophagy selectively degrades dysfunctional mitochondria, maintaining cellular homeostasis; abnormal regulation can promote cancer-associated mitochondrial damage and disease pathogenesis.\"},{\"question\":\"How should mitophagy be targeted for treatment given its dual role?\",\"answer\":\"Because mitophagy can act as either a tumor promoter or suppressor depending on context, therapeutic strategies should focus on precise, individualized modulation rather than simple inhibition or activation.\"}]","Mitophagy in bladder cancer - a double-edged sword in tumor progression and therapy | PDF",1790126421,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b9b8c01bffe90a50d681c3881c5f96b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5915828f39c9d2550ec8518a404a3b81.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f17bec976b59b68fb5fc1cc0b4e34842.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/566b10ca4dfaf684fd1f95fc321aa470.webp",980,1306]